Tumor signatures in the blood

Speicher and Pantel comment on two papers in this issue and one in Science Translational Medicine describing technologies for extracting molecular information about parent tumors from CTCs2, ctDNA3 and exosomes, bringing the prospect of liquid biopsies a few steps closer to reality.

Saved in:
Bibliographic Details
Published inNature biotechnology Vol. 32; no. 5; pp. 441 - 443
Main Authors Speicher, Michael R, Pantel, Klaus
Format Journal Article
LanguageEnglish
Published United States Nature Publishing Group 01.05.2014
Subjects
Biomarkers, Tumor - analysis
Biotechnology
DNA, Neoplasm - blood
Exome - genetics
Exosomes - chemistry
Female
Hematology
High-Throughput Screening Assays - methods
Humans
Male
Molecular biology
Neoplasms - blood
Neoplastic Cells, Circulating
Oncology
Ovarian Neoplasms - metabolism
Prostatic Neoplasms - genetics
Surface Plasmon Resonance - methods
Tumors
Online AccessGet full text

Cover

More Information
Summary:Speicher and Pantel comment on two papers in this issue and one in Science Translational Medicine describing technologies for extracting molecular information about parent tumors from CTCs2, ctDNA3 and exosomes, bringing the prospect of liquid biopsies a few steps closer to reality.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Commentary-1
ObjectType-Feature-1
ISSN:1087-0156
1546-1696
DOI:10.1038/nbt.2897